Test Price
2,800 AED✅ Home Collection Available
STAG1 Gene Prostate Cancer Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO 9001:2015 certified NGS workflow.
- Premium Logistics: VIP mobile phlebotomy with temperature-controlled cold-chain home collection (daily 8 AM – 11 PM).
- Clinical Guidance: Telephonic post-test counselling by a Consultant Medical Geneticist for personalised interpretation.
- Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The STAG1 gene Next-Generation Sequencing (NGS) test screens for pathogenic and likely pathogenic variants in the STAG1 gene associated with hereditary prostate cancer risk. This comprehensive analysis covers the full coding region and splice sites, enabling early risk stratification and personalised surveillance planning under specialist supervision.
| Feature | Our STAG1 NGS Test | Closest Alternative (Standard Single-Gene Test) |
|---|---|---|
| Methodology | Next-Generation Sequencing (NGS) | Sanger Sequencing or PCR-based |
| Target Coverage | Full coding region & splice sites | Limited hotspot analysis |
| Diagnostic Sensitivity | 99.9% | ~85–95% |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks |
| Genetic Counselling | Pre- and post-test included | Often not integrated |
| Price (AED) | 2,800 | Varies, typically lower |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh – Consultant Medical Genetics (DHA Registration ID: 9294403):
“A genetic result is not an oracle; it is a data point. The STAG1 finding must be interpreted alongside family history, PSA trends, and clinical context. Our integrated counselling ensures you understand the implications before making any medical decisions – this test alone does not define your future.”
Advisory & Medication Warning
Do Not Discontinue Prescribed Treatments
Never stop or alter any medication, hormone therapy, or radiation plan without consulting your treating physician. This genetic test is a risk assessment tool and should not replace ongoing oncological or urological care.
Safety Exclusion Criteria & Emergency Red Flags
Exclusion and Urgent Indicators
- Exclusion: The test will not proceed if the individual cannot provide valid informed consent, is under 18 years of age without legal guardian approval, or has an active systemic infection compromising specimen integrity.
- Urgent Red Flags: If you currently have acute urinary retention, severe bone pain (especially back/hips), sudden leg weakness, or unexplained weight loss, seek emergency evaluation immediately. Genetic testing is not appropriate for acute symptom assessment.
Patient FAQ & Clinical Guidance
1. What is the STAG1 gene prostate cancer test?
A: The STAG1 NGS test detects inherited mutations that increase prostate cancer risk. It analyses the entire STAG1 coding region to identify known and novel variants linked to familial disease. Results guide tailored screening plans – such as more frequent PSA and imaging – and always require pre- and post-test genetic counselling.
2. How accurate is the NGS method used?
A: Our NGS platform achieves greater than 99.9% analytical sensitivity and specificity for single nucleotide variants. The test is performed on ISO 9001:2015 certified instruments with deep coverage, reducing false-negative rates to below 0.1%. All variants are confirmed by orthogonal methods and interpreted according to ACMG guidelines, with external quality assessment (EMQN).
3. Who should consider this test?
A: Men with a strong family history of prostate cancer – especially two or more first-degree relatives, or diagnosis under age 60 – should discuss testing with their oncologist. It is also relevant for families with breast, ovarian, or pancreatic cancers suggesting a broader hereditary syndrome. The test helps at-risk individuals pursue proactive risk assessment under specialist supervision.
UAE Regulatory & Data Privacy Adherence
Compliance & Data Protection
All services are conducted in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL), Federal Law No. 2 of 2019 concerning the use of ICT in health fields, and Federal Decree-Law No. 4 of 2016 on Medical Liability. Patient data is encrypted, anonymised for research, and never shared without explicit consent. ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) quality management ensures procedural integrity.
Clinical & Logistical Metadata
| Test Name | STAG1 Gene Prostate Cancer Genetic Test (NGS) |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood (EDTA) – VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection Available |
| Methodology Used | Next-Generation Sequencing (NGS) – Full Coding Region & Splice Sites |
| ICD-10-CM Code | Z80.43 |
| LOINC Code | 21620-6 |
| DHA Facility License & Address | License No. 1143 | DNA Labs UAE, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians